Logo image of AIRS

AIRSCULPT TECHNOLOGIES INC (AIRS) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:AIRS - US0094961002 - Common Stock

3.36 USD
-0.17 (-4.82%)
Last: 12/1/2025, 8:00:00 PM
3.5 USD
+0.14 (+4.17%)
Pre-Market: 12/2/2025, 8:00:00 AM
Fundamental Rating

2

Overall AIRS gets a fundamental rating of 2 out of 10. We evaluated AIRS against 101 industry peers in the Health Care Providers & Services industry. AIRS has a bad profitability rating. Also its financial health evaluation is rather negative. AIRS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year AIRS has reported negative net income.
In the past year AIRS had a positive cash flow from operations.
In multiple years AIRS reported negative net income over the last 5 years.
AIRS had a positive operating cash flow in each of the past 5 years.
AIRS Yearly Net Income VS EBIT VS OCF VS FCFAIRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

AIRS has a Return On Assets of -9.67%. This is in the lower half of the industry: AIRS underperforms 74.26% of its industry peers.
The Return On Equity of AIRS (-21.90%) is worse than 66.34% of its industry peers.
Industry RankSector Rank
ROA -9.67%
ROE -21.9%
ROIC N/A
ROA(3y)-4.48%
ROA(5y)-0.79%
ROE(3y)-12.17%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
AIRS Yearly ROA, ROE, ROICAIRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

AIRS has a Gross Margin of 63.97%. This is amongst the best in the industry. AIRS outperforms 84.16% of its industry peers.
In the last couple of years the Gross Margin of AIRS has remained more or less at the same level.
AIRS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.45%
GM growth 5Y-0.58%
AIRS Yearly Profit, Operating, Gross MarginsAIRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 40 60

0

2. Health

2.1 Basic Checks

AIRS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AIRS has more shares outstanding
Compared to 5 years ago, AIRS has more shares outstanding
Compared to 1 year ago, AIRS has a worse debt to assets ratio.
AIRS Yearly Shares OutstandingAIRS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
AIRS Yearly Total Debt VS Total AssetsAIRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of 1.54, we must say that AIRS is in the distress zone and has some risk of bankruptcy.
AIRS has a Altman-Z score of 1.54. This is in the lower half of the industry: AIRS underperforms 61.39% of its industry peers.
The Debt to FCF ratio of AIRS is 23.08, which is on the high side as it means it would take AIRS, 23.08 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 23.08, AIRS is not doing good in the industry: 61.39% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.63 indicates that AIRS is somewhat dependend on debt financing.
AIRS has a Debt to Equity ratio of 0.63. This is comparable to the rest of the industry: AIRS outperforms 56.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 23.08
Altman-Z 1.54
ROIC/WACCN/A
WACC9.06%
AIRS Yearly LT Debt VS Equity VS FCFAIRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

AIRS has a Current Ratio of 0.51. This is a bad value and indicates that AIRS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of AIRS (0.51) is worse than 87.13% of its industry peers.
AIRS has a Quick Ratio of 0.51. This is a bad value and indicates that AIRS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of AIRS (0.51) is worse than 86.14% of its industry peers.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.51
AIRS Yearly Current Assets VS Current LiabilitesAIRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.14% over the past year.
The Revenue for AIRS has decreased by -16.54% in the past year. This is quite bad
Measured over the past years, AIRS shows a very strong growth in Revenue. The Revenue has been growing by 34.35% on average per year.
EPS 1Y (TTM)7.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)-16.54%
Revenue growth 3Y10.6%
Revenue growth 5Y34.35%
Sales Q2Q%-17.76%

3.2 Future

Based on estimates for the next years, AIRS will show a very strong growth in Earnings Per Share. The EPS will grow by 35.29% on average per year.
AIRS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.37% yearly.
EPS Next Y86.4%
EPS Next 2Y47.69%
EPS Next 3Y35.29%
EPS Next 5YN/A
Revenue Next Year-11.71%
Revenue Next 2Y-3.66%
Revenue Next 3Y0.44%
Revenue Next 5Y2.37%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AIRS Yearly Revenue VS EstimatesAIRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
AIRS Yearly EPS VS EstimatesAIRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 0.2 -0.2 0.3

2

4. Valuation

4.1 Price/Earnings Ratio

AIRS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 123.51 indicates a quite expensive valuation of AIRS.
AIRS's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. AIRS is more expensive than 63.37% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.21. AIRS is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 123.51
AIRS Price Earnings VS Forward Price EarningsAIRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as AIRS.
The rest of the industry has a similar Price/Free Cash Flow ratio as AIRS.
Industry RankSector Rank
P/FCF 85.08
EV/EBITDA 47.74
AIRS Per share dataAIRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

AIRS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as AIRS's earnings are expected to grow with 35.29% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.69%
EPS Next 3Y35.29%

0

5. Dividend

5.1 Amount

AIRS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AIRSCULPT TECHNOLOGIES INC

NASDAQ:AIRS (12/1/2025, 8:00:00 PM)

Premarket: 3.5 +0.14 (+4.17%)

3.36

-0.17 (-4.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)03-12 2026-03-12/amc
Inst Owners28.04%
Inst Owner Change1.48%
Ins Owners26.16%
Ins Owner Change0.3%
Market Cap209.80M
Revenue(TTM)157.55M
Net Income(TTM)-17.98M
Analysts76
Price Target6.63 (97.32%)
Short Float %40.92%
Short Ratio4.74
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP-1.32%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)75.51%
Min EPS beat(2)-96.08%
Max EPS beat(2)247.1%
EPS beat(4)2
Avg EPS beat(4)28.68%
Min EPS beat(4)-103.64%
Max EPS beat(4)247.1%
EPS beat(8)3
Avg EPS beat(8)-16.15%
EPS beat(12)4
Avg EPS beat(12)-36.58%
EPS beat(16)5
Avg EPS beat(16)-86.46%
Revenue beat(2)0
Avg Revenue beat(2)-9.13%
Min Revenue beat(2)-13.2%
Max Revenue beat(2)-5.06%
Revenue beat(4)0
Avg Revenue beat(4)-7.84%
Min Revenue beat(4)-13.2%
Max Revenue beat(4)-1.64%
Revenue beat(8)0
Avg Revenue beat(8)-6.26%
Revenue beat(12)2
Avg Revenue beat(12)-3.89%
Revenue beat(16)5
Avg Revenue beat(16)-2.51%
PT rev (1m)8.33%
PT rev (3m)8.33%
EPS NQ rev (1m)-66.7%
EPS NQ rev (3m)-66.7%
EPS NY rev (1m)0%
EPS NY rev (3m)57.15%
Revenue NQ rev (1m)-7.32%
Revenue NQ rev (3m)-7.32%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 123.51
P/S 1.33
P/FCF 85.08
P/OCF 25.16
P/B 2.56
P/tB N/A
EV/EBITDA 47.74
EPS(TTM)-0.13
EYN/A
EPS(NY)0.03
Fwd EY0.81%
FCF(TTM)0.04
FCFY1.18%
OCF(TTM)0.13
OCFY3.98%
SpS2.52
BVpS1.31
TBVpS-0.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.67%
ROE -21.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.97%
FCFM 1.57%
ROA(3y)-4.48%
ROA(5y)-0.79%
ROE(3y)-12.17%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.45%
GM growth 5Y-0.58%
F-Score3
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 23.08
Debt/EBITDA 9.48
Cap/Depr 45.53%
Cap/Sales 3.73%
Interest Coverage N/A
Cash Conversion 152.38%
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.51
Altman-Z 1.54
F-Score3
WACC9.06%
ROIC/WACCN/A
Cap/Depr(3y)124.96%
Cap/Depr(5y)109.63%
Cap/Sales(3y)6.83%
Cap/Sales(5y)6.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y86.4%
EPS Next 2Y47.69%
EPS Next 3Y35.29%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.54%
Revenue growth 3Y10.6%
Revenue growth 5Y34.35%
Sales Q2Q%-17.76%
Revenue Next Year-11.71%
Revenue Next 2Y-3.66%
Revenue Next 3Y0.44%
Revenue Next 5Y2.37%
EBIT growth 1Y-300.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year34.56%
EBIT Next 3Y20.93%
EBIT Next 5YN/A
FCF growth 1Y-84.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-67.59%
OCF growth 3Y-24.74%
OCF growth 5Y18.1%

AIRSCULPT TECHNOLOGIES INC / AIRS FAQ

What is the ChartMill fundamental rating of AIRSCULPT TECHNOLOGIES INC (AIRS) stock?

ChartMill assigns a fundamental rating of 2 / 10 to AIRS.


What is the valuation status for AIRS stock?

ChartMill assigns a valuation rating of 2 / 10 to AIRSCULPT TECHNOLOGIES INC (AIRS). This can be considered as Overvalued.


What is the profitability of AIRS stock?

AIRSCULPT TECHNOLOGIES INC (AIRS) has a profitability rating of 2 / 10.


Can you provide the dividend sustainability for AIRS stock?

The dividend rating of AIRSCULPT TECHNOLOGIES INC (AIRS) is 0 / 10 and the dividend payout ratio is -1.32%.